- Sorrento Therapeutics (NASDAQ:SRNE) +30% on FDA nod for early-stage COVID-19 antibody trial.
- More news on: Sorrento Therapeutics, Inc., Hepion Pharmaceuticals, Inc., Vaccinex, Inc., , Stocks on the move, Read more ...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Elys Game Technology, Corp. (formerly Newgioco Group, Inc.) (“Elys” or the “Company”) (Nasdaq:ELYS), an interactive gaming and sports betting technology company, is pleased to announce the Company has changed its name from Newgioco Group, Inc. to Elys Game Te...
Newgioco Group, Inc. (“Newgioco” or the “Company”) (Nasdaq: NWGI), a global sports betting and interactive gaming technology company, is pleased to announce that the Company has received Gaming Labs International (GLI®) certification to the GLI 20: Stand...
Newgioco Group, Inc. (“Newgioco” or the “Company”) (Nasdaq: NWGI), a global sports betting and interactive gaming technology company providing a cutting-edge fully integrated, omni-channel sports betting technology, announced initiation of research coverage p...